Helical plc (LON:HLCL)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	274	243	257	370	503	501
Market Cap Growth	-5.29%	-5.29%	-30.67%	-26.39%	0.26%	19.41%
Enterprise Value	373	367	453	568	716	817
Last Close Price	2.22	1.94	2.02	2.78	3.69	3.63
PE Ratio	9.78	8.70	-	-	5.66	28.05
PS Ratio	8.22	7.29	6.78	7.59	9.57	13.99
PB Ratio	0.64	0.57	0.64	0.61	0.73	0.83
P/OCF Ratio	190.14	168.76	20.90	482.48	101.98	125.26
EV/Sales Ratio	11.19	11.02	11.96	11.66	13.63	22.80
EV/EBITDA Ratio	41.39	40.78	31.07	24.56	32.09	88.52
EV/EBIT Ratio	48.53	47.81	34.66	25.44	33.23	96.82
Debt / Equity Ratio	0.41	0.41	0.58	0.38	0.59	0.58
Debt / EBITDA Ratio	19.49	19.49	15.92	10.07	18.10	38.11
Asset Turnover	0.05	0.05	0.05	0.05	0.05	0.04
Inventory Turnover	184.30	184.30	516.07	12.82	11.22	19.98
Quick Ratio	3.74	3.74	1.61	2.32	1.64	3.96
Current Ratio	3.80	3.80	3.44	2.38	1.79	4.07
Return on Equity (ROE)	6.76%	6.76%	-37.60%	-9.96%	13.73%	2.96%
Return on Assets (ROA)	0.75%	0.75%	1.07%	1.39%	1.25%	0.52%
Return on Capital (ROIC)	0.78%	0.78%	1.11%	1.44%	1.31%	0.55%
Earnings Yield	10.21%	11.50%	-73.98%	-17.43%	17.68%	3.56%
Dividend Yield	2.25%	2.58%	2.39%	4.23%	3.02%	2.78%
Payout Ratio	14.40%	14.41%	-	-	14.15%	58.89%
Buyback Yield / Dilution	-0.21%	-0.21%	-0.01%	1.37%	-1.06%	-0.76%
Total Shareholder Return	1.99%	2.36%	2.38%	5.60%	1.96%	2.02%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.